Percutaneous myocardial ablation in double-chamber right ventricle

E Tsuchikane1, T Kobayashi, M Kirino

  • 1Department of Cardiology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan. oscmed1@skyblue.ocn.ne.jp

Insights

Percutaneous myocardial ablation using alcohol injection successfully treated double-chamber right ventricle (DCRV) in an adult. This minimally invasive technique reduced the pressure gradient and improved the patient's condition, offering a potential surgical alternative.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Double-chamber right ventricle (DCRV) is a congenital heart defect characterized by intracavitary outflow obstruction.
  • Surgical intervention is the traditional treatment for DCRV, but carries significant risks, especially in elderly patients.

Observation:

  • A 73-year-old patient with symptomatic DCRV presented with significant intracavitary outflow obstruction.
  • The patient was deemed a high-risk candidate for conventional surgical treatment.

Findings:

  • The study reports the first successful percutaneous myocardial ablation of DCRV using alcohol-induced conus branch occlusion.
  • This minimally invasive procedure resulted in a significant reduction of the pressure gradient from 81 to 48 mm Hg.
  • The patient experienced notable clinical improvement following the intervention.

Implications:

  • Percutaneous myocardial ablation represents a promising alternative therapeutic strategy for adult patients with DCRV.
  • This approach may offer a less invasive option compared to traditional surgery, particularly for high-risk individuals.
  • Further research is warranted to establish the long-term efficacy and safety of this technique.